mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-06 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-05 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-05 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
3e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |